Premier Alternatives

Granata Bio

Duxbury, MA · Founded 2018 · Privately Held (backing)

Operator of a biopharma company intended to find and grow fertility programs for patients. Granata Bio is based in Duxbury, MA and was founded in 2018. It was valued at $129 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $31.1 million across 2 recorded rounds; the latest was a $13.8 million early-stage round in Dec 2024.

PMV mark · valuation
$129.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$31.1M
Last round
Early Stage VC
Dec 2024

Granata Bio key facts

as of Oct 2026
  • Operator of a biopharma company intended to find and grow fertility programs for patients.
  • Granata Bio is valued at approximately $129.0M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $31.1M across 2 recorded rounds; the latest was Early Stage VC ($13.8M) in Dec 2024.
  • Notable investors include Alumni Ventures, Mana Ventures, Gaingels, GV, What If Ventures — 9 tracked in total.
  • Granata Bio has filed 2 Form Ds with the SEC since 2023, most recently Dec 2024 ($13.8M sold to 3 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$129.0M

Valued at $129.0M at its later-stage round, Dec 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Granata Bio with a free account
  • ·Watch Granata Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Granata Bio funding rounds

2 rounds
Dec 2024Early Stage VC$13.8MSEC filing▮
Oct 2023Early Stage VC$10.1MSEC filing▮
Full funding history →

Granata Bio valuation

Granata Bio was valued at $129 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Granata Bio raised?

Granata Bio has raised $31.1 million in total; 2 of its rounds are on record. The largest on record was a $13.8 million early-stage round in Dec 2024.

Granata Bio has filed 2 Form Ds with the SEC since 2023, most recently in Dec 2024 ($13.8 million sold to 3 investors).

Granata Bio investors

9 investors are on record for Granata Bio, including Alumni Ventures, Mana Ventures, Gaingels and GV. By type, the record holds 6 venture capital firms. The early-stage round in Dec 2024 drew 3 investors.

About Granata Bio

Operator of a biopharma company intended to find and grow fertility programs for patients. The company creates a robust fertility therapeutic portfolio and brings expertise in commercialization as well as late-stage clinical and regulatory development, enabling medical professionals to overcome significant barriers to fertility treatment.

Sector
Healthcare
HQ
Duxbury, MA, United States
Founded
2018
Employees
16
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.